Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endometriosis | 10 | 2019 | 130 | 3.40 | Why? |
| Rectal Diseases | 10 | 2019 | 111 | 2.84 | Why? |
| Peritoneal Neoplasms | 6 | 2019 | 110 | 1.54 | Why? |
| Peritonitis | 4 | 2019 | 217 | 1.37 | Why? |
| Diverticulitis | 2 | 2018 | 65 | 1.34 | Why? |
| Digestive System Surgical Procedures | 6 | 2020 | 677 | 1.23 | Why? |
| Colectomy | 5 | 2019 | 327 | 1.09 | Why? |
| Colostomy | 3 | 2018 | 33 | 1.07 | Why? |
| Cytoreduction Surgical Procedures | 6 | 2019 | 144 | 1.03 | Why? |
| Laparoscopy | 10 | 2020 | 1532 | 0.96 | Why? |
| Colon, Sigmoid | 2 | 2017 | 22 | 0.76 | Why? |
| Rectum | 4 | 2018 | 495 | 0.73 | Why? |
| Digestive System Neoplasms | 1 | 2020 | 146 | 0.72 | Why? |
| Constipation | 1 | 2019 | 99 | 0.71 | Why? |
| Surgical Staplers | 1 | 2017 | 3 | 0.70 | Why? |
| Colonic Diseases | 5 | 2019 | 96 | 0.69 | Why? |
| Surgical Stomas | 1 | 2017 | 33 | 0.69 | Why? |
| Surgical Stapling | 1 | 2017 | 19 | 0.68 | Why? |
| Carcinoma, Pancreatic Ductal | 4 | 2019 | 112 | 0.67 | Why? |
| Hyperthermia, Induced | 4 | 2019 | 106 | 0.66 | Why? |
| Colorectal Neoplasms | 3 | 2021 | 1884 | 0.65 | Why? |
| Organ Sparing Treatments | 1 | 2017 | 91 | 0.64 | Why? |
| Hepatic Veins | 1 | 2017 | 54 | 0.64 | Why? |
| Postoperative Complications | 13 | 2019 | 5861 | 0.60 | Why? |
| Digestive System Diseases | 1 | 2020 | 378 | 0.57 | Why? |
| Pancreatic Neoplasms | 5 | 2019 | 609 | 0.53 | Why? |
| Carcinoma, Papillary | 3 | 2019 | 76 | 0.52 | Why? |
| Hepatectomy | 1 | 2017 | 276 | 0.51 | Why? |
| Anastomosis, Surgical | 5 | 2019 | 169 | 0.46 | Why? |
| Pregnancy Rate | 5 | 2018 | 134 | 0.46 | Why? |
| Rectal Neoplasms | 5 | 2017 | 278 | 0.44 | Why? |
| Chemotherapy, Cancer, Regional Perfusion | 2 | 2019 | 3 | 0.38 | Why? |
| Diverticulitis, Colonic | 2 | 2019 | 38 | 0.38 | Why? |
| Adenocarcinoma, Mucinous | 2 | 2018 | 27 | 0.37 | Why? |
| Postoperative Period | 3 | 2021 | 651 | 0.37 | Why? |
| Mesothelioma | 2 | 2019 | 76 | 0.36 | Why? |
| Liver Neoplasms | 2 | 2018 | 1666 | 0.35 | Why? |
| France | 11 | 2021 | 12074 | 0.33 | Why? |
| Intestinal Perforation | 2 | 2019 | 178 | 0.31 | Why? |
| Carcinoma | 2 | 2017 | 256 | 0.26 | Why? |
| Colonic Neoplasms | 2 | 2018 | 295 | 0.26 | Why? |
| Pancreatectomy | 3 | 2018 | 87 | 0.23 | Why? |
| Aneurysm | 2 | 2018 | 117 | 0.23 | Why? |
| Time-to-Pregnancy | 2 | 2018 | 3 | 0.22 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.22 | Why? |
| Rupture, Spontaneous | 2 | 2018 | 115 | 0.21 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.20 | Why? |
| Adenocarcinoma | 2 | 2017 | 651 | 0.20 | Why? |
| Hernia, Hiatal | 1 | 2019 | 16 | 0.20 | Why? |
| Treatment Outcome | 18 | 2019 | 51732 | 0.20 | Why? |
| Thoracotomy | 1 | 2019 | 85 | 0.19 | Why? |
| Ascitic Fluid | 1 | 2020 | 169 | 0.19 | Why? |
| Portal System | 1 | 2018 | 9 | 0.19 | Why? |
| Peritoneum | 1 | 2018 | 54 | 0.19 | Why? |
| Ileal Neoplasms | 1 | 2018 | 6 | 0.19 | Why? |
| Myoblasts | 1 | 2018 | 24 | 0.19 | Why? |
| Meckel Diverticulum | 1 | 2018 | 6 | 0.19 | Why? |
| Esophagectomy | 1 | 2019 | 76 | 0.19 | Why? |
| Cystostomy | 1 | 2017 | 3 | 0.18 | Why? |
| Pancreatic Ducts | 1 | 2018 | 29 | 0.18 | Why? |
| Hospital Restructuring | 1 | 2020 | 188 | 0.18 | Why? |
| Fecal Incontinence | 1 | 2018 | 40 | 0.18 | Why? |
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2017 | 11 | 0.18 | Why? |
| Herniorrhaphy | 1 | 2019 | 99 | 0.18 | Why? |
| CA-19-9 Antigen | 1 | 2017 | 22 | 0.18 | Why? |
| Hemostatic Techniques | 1 | 2018 | 60 | 0.17 | Why? |
| Transanal Endoscopic Microsurgery | 1 | 2016 | 5 | 0.17 | Why? |
| DNA, Neoplasm | 1 | 2017 | 56 | 0.17 | Why? |
| Capecitabine | 1 | 2017 | 51 | 0.17 | Why? |
| Transanal Endoscopic Surgery | 1 | 2017 | 19 | 0.17 | Why? |
| Gastrointestinal Stromal Tumors | 1 | 2018 | 84 | 0.17 | Why? |
| Ureter | 1 | 2017 | 59 | 0.17 | Why? |
| Organ Preservation | 1 | 2017 | 49 | 0.17 | Why? |
| DNA Copy Number Variations | 1 | 2017 | 84 | 0.17 | Why? |
| Neoadjuvant Therapy | 2 | 2017 | 554 | 0.17 | Why? |
| Ligation | 1 | 2017 | 84 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.16 | Why? |
| Neoplastic Cells, Circulating | 1 | 2017 | 68 | 0.16 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2017 | 99 | 0.16 | Why? |
| Operative Time | 4 | 2019 | 450 | 0.16 | Why? |
| Lymph Node Excision | 1 | 2019 | 362 | 0.16 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.15 | Why? |
| Monitoring, Intraoperative | 1 | 2017 | 140 | 0.15 | Why? |
| Receptor, ErbB-2 | 1 | 2017 | 267 | 0.15 | Why? |
| Bile Duct Neoplasms | 1 | 2018 | 172 | 0.15 | Why? |
| Awareness | 1 | 2020 | 529 | 0.15 | Why? |
| Gastrointestinal Neoplasms | 1 | 2020 | 392 | 0.14 | Why? |
| Prospective Studies | 10 | 2019 | 43301 | 0.14 | Why? |
| Female | 36 | 2021 | 380317 | 0.14 | Why? |
| Chemoradiotherapy | 1 | 2017 | 362 | 0.14 | Why? |
| Quality of Life | 5 | 2019 | 9820 | 0.14 | Why? |
| Humans | 46 | 2021 | 930598 | 0.14 | Why? |
| Postoperative Care | 1 | 2020 | 755 | 0.14 | Why? |
| Registries | 3 | 2019 | 12327 | 0.14 | Why? |
| Prognosis | 10 | 2019 | 32490 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Ultrasonography, Doppler | 1 | 2017 | 406 | 0.13 | Why? |
| Adult | 25 | 2021 | 244371 | 0.13 | Why? |
| Disposable Equipment | 1 | 2016 | 332 | 0.12 | Why? |
| Receptors, Cell Surface | 1 | 2017 | 586 | 0.12 | Why? |
| Fertility | 1 | 2017 | 367 | 0.12 | Why? |
| Colon | 1 | 2018 | 669 | 0.12 | Why? |
| Follow-Up Studies | 10 | 2019 | 17020 | 0.12 | Why? |
| Lymph Nodes | 1 | 2019 | 1060 | 0.12 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.11 | Why? |
| Survival Rate | 7 | 2019 | 9206 | 0.11 | Why? |
| Middle Aged | 25 | 2021 | 270681 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Databases, Factual | 4 | 2019 | 6248 | 0.10 | Why? |
| Neoplasm Staging | 4 | 2019 | 1999 | 0.10 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Antineoplastic Agents | 3 | 2020 | 3550 | 0.09 | Why? |
| Aged, 80 and over | 11 | 2021 | 88759 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Robotic Surgical Procedures | 1 | 2016 | 787 | 0.09 | Why? |
| Risk | 1 | 2020 | 5288 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Hospitals, University | 2 | 2018 | 4173 | 0.08 | Why? |
| Reconstructive Surgical Procedures | 1 | 2017 | 860 | 0.08 | Why? |
| Aged | 19 | 2021 | 215776 | 0.08 | Why? |
| Retrospective Studies | 14 | 2021 | 105322 | 0.08 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.08 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.08 | Why? |
| Proto-Oncogene Proteins B-raf | 2 | 2018 | 179 | 0.08 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.08 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.08 | Why? |
| Lymphatic Metastasis | 2 | 2019 | 537 | 0.07 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.07 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Male | 22 | 2021 | 367725 | 0.07 | Why? |
| Chemotherapy, Adjuvant | 2 | 2018 | 606 | 0.07 | Why? |
| Pregnancy | 5 | 2018 | 23879 | 0.07 | Why? |
| Duodenum | 1 | 2005 | 179 | 0.07 | Why? |
| Proctoscopy | 1 | 2003 | 28 | 0.07 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Imaging, Three-Dimensional | 2 | 2018 | 680 | 0.06 | Why? |
| Elective Surgical Procedures | 1 | 2021 | 5338 | 0.06 | Why? |
| C-Reactive Protein | 1 | 2019 | 7972 | 0.06 | Why? |
| Pancreatic Diseases | 1 | 2005 | 191 | 0.06 | Why? |
| Disease-Free Survival | 2 | 2017 | 1654 | 0.06 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.06 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.05 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| ras Proteins | 1 | 2018 | 37 | 0.05 | Why? |
| Combined Modality Therapy | 2 | 2019 | 3395 | 0.05 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2005 | 669 | 0.05 | Why? |
| Mesenteric Artery, Superior | 1 | 2018 | 29 | 0.05 | Why? |
| Pelvic Neoplasms | 1 | 2018 | 25 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| DCC Receptor | 1 | 2017 | 1 | 0.04 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.04 | Why? |
| Loss of Heterozygosity | 1 | 2017 | 14 | 0.04 | Why? |
| Esthetics | 1 | 2018 | 136 | 0.04 | Why? |
| Colonography, Computed Tomographic | 1 | 2018 | 58 | 0.04 | Why? |
| Mesentery | 1 | 2017 | 43 | 0.04 | Why? |
| Matched-Pair Analysis | 1 | 2017 | 83 | 0.04 | Why? |
| Feasibility Studies | 2 | 2019 | 3467 | 0.04 | Why? |
| Rectal Fistula | 1 | 2017 | 38 | 0.04 | Why? |
| Chemoradiotherapy, Adjuvant | 1 | 2017 | 69 | 0.04 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 100 | 0.04 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 75 | 0.04 | Why? |
| Peripheral Nerves | 1 | 2017 | 74 | 0.04 | Why? |
| Pancreaticoduodenectomy | 1 | 2017 | 60 | 0.04 | Why? |
| Injections | 1 | 2018 | 237 | 0.04 | Why? |
| Margins of Excision | 1 | 2017 | 122 | 0.04 | Why? |
| Neoplasm, Residual | 1 | 2017 | 147 | 0.04 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Live Birth | 1 | 2018 | 200 | 0.04 | Why? |
| Fertility Preservation | 1 | 2018 | 121 | 0.04 | Why? |
| Induction Chemotherapy | 1 | 2017 | 149 | 0.04 | Why? |
| Microsatellite Repeats | 1 | 2017 | 99 | 0.04 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.04 | Why? |
| Intraoperative Complications | 1 | 2018 | 221 | 0.04 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.04 | Why? |
| Tertiary Care Centers | 3 | 2019 | 8248 | 0.04 | Why? |
| Aorta | 1 | 2019 | 355 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.03 | Why? |
| Esophageal Neoplasms | 1 | 2019 | 357 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.03 | Why? |
| North America | 1 | 2018 | 1400 | 0.03 | Why? |
| Rare Diseases | 1 | 2018 | 373 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2019 | 9537 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.03 | Why? |
| Colonoscopy | 1 | 2018 | 738 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.02 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.02 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.02 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Urologic Diseases | 1 | 2016 | 860 | 0.02 | Why? |
| Palliative Care | 1 | 2003 | 2665 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Splenic Artery | 1 | 2005 | 18 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.02 | Why? |
| Australia | 1 | 2018 | 6306 | 0.02 | Why? |
| Splenectomy | 1 | 2005 | 85 | 0.02 | Why? |
| Proctoscopes | 1 | 2003 | 2 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |
Tuech's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_